Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1
- 1 August 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 185 (1), 103-106
- https://doi.org/10.1016/0014-2999(90)90216-s
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Intravascular big endothelin increases circulating levels of endothelin-1 and prostanoids in the rabbitBiochemical Pharmacology, 1990
- Evidence for pepstatin-sensitive conversion of porcine big endothelin-1 to endothelin-1 by the endothelial cell extractBiochemical and Biophysical Research Communications, 1990
- Conversion of porcine big endothelin to endothelin by an extract from the porcine aortic endothelial cellsBiochemical and Biophysical Research Communications, 1990
- Receptor binding and vasoconstrictor activity of big endothelinEuropean Journal of Pharmacology, 1990
- Analysis of endothelin related peptides in culture supernatant of porcine aortic endothelial cells: Evidence for biosynthetic pathway of endothelin-1Biochemical and Biophysical Research Communications, 1989
- Concomitant secretion of big endothelin and its C-terminal fragment from human and bovine endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivoFEBS Letters, 1989
- Conversion of Big Endothelin-1 to 21-Residue Endothelin-1 Is Essential for Expression of Full Vasoconstrictor ActivityJournal of Cardiovascular Pharmacology, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- Studies on inhibitory effect of phosphoramidon and its analogs on thermolysinArchives of Biochemistry and Biophysics, 1975